{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:08:05Z","timestamp":1792033685387,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2015,8,23]],"date-time":"2015-08-23T00:00:00Z","timestamp":1440288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s11010-015-2526-8","type":"journal-article","created":{"date-parts":[[2015,8,22]],"date-time":"2015-08-22T07:42:23Z","timestamp":1440229343000},"page":"213-224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Methotrexate modulates the expression of MMP-1 and type 1 collagen in dermal fibroblast"],"prefix":"10.1007","volume":"409","author":[{"given":"Layla","family":"Nabai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhangiz T.","family":"Kilani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzian","family":"Aminuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Ghahary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,23]]},"reference":[{"key":"2526_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1755-1536-2-7","volume":"2","author":"CZ Chen","year":"2009","unstructured":"Chen CZ, Raghunath M (2009) Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis\u2014state of the art. Fibrogenesis Tissue Repair 2:7. doi: 10.1186\/1755-1536-2-7","journal-title":"Fibrogenesis Tissue Repair"},{"key":"2526_CR2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2119\/molmed.2009.00153","volume":"17","author":"GG Gauglitz","year":"2011","unstructured":"Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG (2011) Hypertrophic scarring and keloids: pathomaechanisms and Current and emerging treatment strategies. Mol Med 17:113\u2013125. doi: 10.2119\/molmed.2009.00153","journal-title":"Mol Med"},{"key":"2526_CR3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1523-1747.1999.00528.x","volume":"112","author":"T Yamamoto","year":"1999","unstructured":"Yamamoto T, Takagawa S, Katayama I, Yamazaki K, Hamazaki Y, Shinkai H, Nishioka K (1999) Animal model of sclerotic skin. I: local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol 112:456\u2013462","journal-title":"J Invest Dermatol"},{"key":"2526_CR4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/SAP.0b013e3181afaab0","volume":"64","author":"SM Shridharani","year":"2010","unstructured":"Shridharani SM, Magarakis M, Manson PN, Singh NK, Basdag B, Rosson GD (2010) The emerging role of antineoplastic agents in the treatment of keloids and hypertrophic scars: a review. Ann Plast Surg 64:355\u2013361. doi: 10.1097\/SAP.0b013e3181afaab0","journal-title":"Ann Plast Surg"},{"key":"2526_CR5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/ard.2005.044354","volume":"66","author":"B Combe","year":"2007","unstructured":"Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M et al (2007) EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 66:34\u201345","journal-title":"Ann Rheum Dis"},{"key":"2526_CR6","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","volume":"59","author":"KG Saag","year":"2008","unstructured":"Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR et al (2008) American College of Rheumatology 2008 recommendations for the use of non biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthr Rheum 59:762\u2013784. doi: 10.1002\/art.23721","journal-title":"Arthr Rheum"},{"key":"2526_CR7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1067\/mjd.2001.117047","volume":"45","author":"M Lebwohl","year":"2001","unstructured":"Lebwohl M, Ali S (2001) Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol 45:649\u2013661","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2526_CR8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1468-3083.2011.03991.x","volume":"25","author":"H Montaudi\u00e9","year":"2011","unstructured":"Montaudi\u00e9 H, Sbidian E, Paul C et al (2011) Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity. J Eur Acad Dermatol Venereol 25(2):12\u201318. doi: 10.1111\/jdv.12562","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2526_CR9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12016-008-8114-x","volume":"36","author":"Kalliopi K Vasiliki","year":"2009","unstructured":"Vasiliki Kalliopi K, Bournia Panayiotis G, Vlachoyiannopoulos Carlo Selmi, Moutsopoulos Haralampos M, Eric Gershwin M (2009) Recent Advances in the treatment of systemic sclerosis. Clin Rev Allergy Immunol 36:176\u2013200. doi: 10.1007\/s12016-008-8114-x","journal-title":"Clin Rev Allergy Immunol"},{"key":"2526_CR10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1001\/archderm.1980.01640260034004","volume":"116","author":"MF Onwukwe","year":"1980","unstructured":"Onwukwe MF (1980) Treating Keloids by surgery and methotrexate. Arch Dermatol 116:158","journal-title":"Arch Dermatol"},{"key":"2526_CR11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jhsa.2003.10.017","volume":"29","author":"Arshad R Muzaffar","year":"2004","unstructured":"Muzaffar Arshad R, Rafols Francisco, Masson James, Ezaki Marybeth, Peter R (2004) Carter. Keloid formation after syndactyly reconstruction: associated conditions, prevalence, and preliminary report of a treatment method. J Hand Surg Am 29:201\u2013208","journal-title":"J Hand Surg Am"},{"key":"2526_CR12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/1753193411402146","volume":"36","author":"SK Tolerton","year":"2011","unstructured":"Tolerton SK, Tonkin MA (2011) Keloid formation after syndactyly release in patients with associated macrodactyly: management with methotrexate therapy. J Hand Surg Eur 36:490\u2013497. doi: 10.1177\/1753193411402146","journal-title":"J Hand Surg Eur"},{"key":"2526_CR13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11010-011-0788-3","volume":"353","author":"M Carr","year":"2011","unstructured":"Carr M, Chavez-Mu\u0148oz C, Lai A, Ghahary A (2011) Dermal fibroblasts influence the expression profile of 14-3-3 proteins in human keratinocytes. Mol Cell Biochem 353:205\u2013214. doi: 10.1007\/s11010-011-0788-3","journal-title":"Mol Cell Biochem"},{"key":"2526_CR14","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/jcb.10256","volume":"86","author":"F Karimi-Busheri","year":"2002","unstructured":"Karimi-Busheri F, Marcoux Y, Tredget EE, Li L, Zheng J, Ghoreishi M, Weinfeld M, Ghahary A (2002) Expression of a releasable form of annexin II by human keratinocytes. J Cell Biochem 86:737\u2013747","journal-title":"J Cell Biochem"},{"key":"2526_CR15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0889-857X(05)70359-8","volume":"23","author":"JL Hillson","year":"1997","unstructured":"Hillson JL, Frust DE (1997) Pharmacology and pharmacokinetics of methotrexate in rheumatic disease. Practical issues in treatment and design. Rheum Dis Clin North Am 23:757\u2013778","journal-title":"Rheum Dis Clin North Am"},{"key":"2526_CR16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/1523-1747.ep12343658","volume":"106","author":"A Ghahary","year":"1996","unstructured":"Ghahary A, Shen YJ, Nedelec B, Wang R, Scott PG, Tredget EE (1996) Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1. J Invest Dermatol 106:476\u2013481","journal-title":"J Invest Dermatol"},{"key":"2526_CR17","doi-asserted-by":"crossref","first-page":"32360","DOI":"10.1074\/jbc.M204296200","volume":"277","author":"N Reunanen","year":"2002","unstructured":"Reunanen N, Li SP, Ahonen M, Foschi M, Han J, Kahari VM (2002) Activation of p38 alpha MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization. J Biol Chem 277:32360\u201332368","journal-title":"J Biol Chem"},{"key":"2526_CR18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jdermsci.2011.07.002","volume":"64","author":"CH Park","year":"2011","unstructured":"Park CH, Chung JH (2011) Epidermal growth factor-induced matrix metalloproteinase-1 expression is negatively regulated by p38 MAPK in human skin fibroblasts. J Dermatol Sci 64:134\u2013141. doi: 10.1016\/j.jdermsci.2011.07.002","journal-title":"J Dermatol Sci"},{"key":"2526_CR19","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1128\/IAI.72.5.2864-2871.2004","volume":"72","author":"AK Behera","year":"2004","unstructured":"Behera AK, Thorpe CM, Kidder JM, Smith W, Hildebrand E, Hu LT (2004) Borrelia burgdorferi-induced expression of matrix metalloproteinases from human chondrocytes require mitogen-activated protein kinase and janus kinase\/signal transducer and activator of transcription signaling pathways. Infect Immun 72:2864\u20132871","journal-title":"Infect Immun"},{"key":"2526_CR20","doi-asserted-by":"crossref","first-page":"H3356","DOI":"10.1152\/ajpheart.00928.2007","volume":"293","author":"DM Cortez","year":"2007","unstructured":"Cortez DM, Feldman MD, Mummidi S et al (2007) IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1\/2-dependent C\/EBP-beta, NF-kappaB, and AP-1 activation. Am J Physiol Heart Circ Physiol 293:H3356\u2013H3365","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2526_CR21","first-page":"238","volume":"20","author":"FA Meyer","year":"1993","unstructured":"Meyer FA, Yaron I, Mashiah V, Yaron M (1993) Methotrexate inhibits proliferation but not interleukin 1 stimulated secretory activities of cultured human synovial fibroblasts. J Rheumatol 20:238\u2013242","journal-title":"J Rheumatol"},{"key":"2526_CR22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1468-3083.2007.02322.x","volume":"22","author":"SC Carneiro","year":"2008","unstructured":"Carneiro SC, Cassia FF, Lamy F, Chagas VLA, Ramos-e-Silva M (2008) Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages. J Eur Acad Dermatol Venerol 22:25\u201329","journal-title":"J Eur Acad Dermatol Venerol"},{"issue":"2","key":"2526_CR23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-3083.2011.03990.x","volume":"25","author":"C Paul","year":"2011","unstructured":"Paul C, Gallini A, Maza A et al (2011) Evidence-based recommendations on conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol 25(2):2\u201311. doi: 10.1111\/j.1468-3083.2011.03990.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2526_CR24","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/rheumatology\/kel075","volume":"45","author":"V Sarvanan","year":"2006","unstructured":"Sarvanan V, Kelly C (2006) Drug-related pulmonary problems in patients with rheumatoid arthritis. Rheumatology 45:787\u2013789. doi: 10.1503\/cmaj.091391","journal-title":"Rheumatology"},{"key":"2526_CR25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1172\/JCI1554","volume":"101","author":"L Morabito","year":"1998","unstructured":"Morabito L, Montesinos MC, Schreibman DM et al (1998) Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5\u2032-nucleotidase-mediated conversion of adenine nucleotides. J Clin Invest 101:295\u2013300","journal-title":"J Clin Invest"},{"key":"2526_CR26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrrheum.2010.5","volume":"6","author":"ES Chan","year":"2010","unstructured":"Chan ES, Cronstein BN (2010) Methotrexate\u2013how does it really work? Nat Rev Rheumatol 6:175\u2013178. doi: 10.1038\/nrrheum.2010.5","journal-title":"Nat Rev Rheumatol"},{"key":"2526_CR27","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.bjp.0706812","volume":"148","author":"ESL Chan","year":"2006","unstructured":"Chan ESL, Montesinos MC, Fernandez P, Desai A, Delano DL, Yee H, Reiss AB, Pillinger MH, Chen JF, Schwarzschild MA, Friedman SL, Cronstein BN (2006) Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis. Br J Pharmacol 148:1144\u20131155","journal-title":"Br J Pharmacol"},{"key":"2526_CR28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3410\/B3-21","volume":"3","author":"BN Cronstein","year":"2011","unstructured":"Cronstein BN (2011) Adenosine receptors and fibrosis: a translational review. F1000 Biol Rep 3:21. doi: 10.3410\/B3-21","journal-title":"F1000 Biol Rep"},{"key":"2526_CR29","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/ar4229","volume":"15","author":"ES Chan","year":"2013","unstructured":"Chan ES, Liu H, Fernandez P, Luna A, Perez-Aso M, Bujor AM, Trojanowska M, Cronstein BN (2013) Adenosine A(2A) receptors promote collagen production by a Fli1- and CTGF-mediated mechanism. Arthritis Res Ther 15:R58","journal-title":"Arthritis Res Ther"},{"key":"2526_CR30","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.4049\/jimmunol.175.3.1937","volume":"175","author":"JL Chunn","year":"2005","unstructured":"Chunn JL, Molina JG, Mi T, Xia Y, Kellems RE, Blackburn MR (2005) Adenosine-dependent pulmonary fibrosis in adenosine deaminase-deficient mice. J Immunol 175:1937\u20131946","journal-title":"J Immunol"},{"key":"2526_CR31","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2131\/jts.35.653","volume":"35","author":"M Ohbayashi","year":"2010","unstructured":"Ohbayashi M, Suzuki M, Yashiro Y, Fukuwaka S, Yasuda M, Kohyama N, Kobayashi Y, Yamamoto T (2010) Induction of pulmonary fibrosis by methotrexate treatment in mice lung in vivo and in vitro. J Toxicol Sci 35:653\u2013661","journal-title":"J Toxicol Sci"},{"key":"2526_CR32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/s10165-009-0251-4","volume":"20","author":"ES Chan","year":"2010","unstructured":"Chan ES, Cronstein BN (2010) Adenosine in fibrosis. Mod Rheumatol 20:114\u2013122","journal-title":"Mod Rheumatol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-015-2526-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-015-2526-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-015-2526-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T17:53:39Z","timestamp":1718042019000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-015-2526-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,23]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["2526"],"URL":"https:\/\/doi.org\/10.1007\/s11010-015-2526-8","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,23]]}}}